The Magazine for Sleep Professionals
Thursday, July 23, 2026
A new commentary published online in the Annals of the American Thoracic Society provides an exhaustive examination of published research that discusses whether air pollution may be linked to worse COVID-19 outcomes. The studies that the authors examined look at several potential disease mechanisms, and also at the relationship between pollution, respiratory viruses and health disparities. […]
Apnimed raised $25 million in a Series B financing led by existing investor, Morningside Ventures, and joined by new investors, Seligman Investments and Tao Capital Partners. The proceeds will support Apnimed’s ongoing development and commercialization plans. The company is advancing its lead program, AD109, an oral disease-modifying therapeutic for the […]
A new study published online in the Annals of the American Thoracic Society reveals how socioeconomic factors partially explain the increased odds that Black and Hispanic Americans have of testing positive for SARS-CoV-2, the virus that causes COVID-19. In “Association of Race and Ethnicity With COVID-19 Test Positivity and Hospitalization Is Mediated by […]
Rokote Laboratories Finland Ltd., a newly-founded academic spin-out based in Finland is working to develop and introduce to the markets a nasal spray vaccine against COVID. The vaccine is based on research carried out at the University of Helsinki and the University of Eastern Finland. The vaccine uses gene transfer […]
Joe Alesch served for 26 years as a respiratory therapist at INTEGRIS Health before his retirement in 2019. During his retirement, he went to Colorado Springs every six weeks to visit his father who was living in a retirement center there. “I always looked forward to those trips,” Alesch said. […]
Masks help protect the people wearing them from getting or spreading SARS-CoV-2, the virus that causes COVID-19, but now researchers from the National Institutes of Health have added evidence for yet another potential benefit for wearers: The humidity created inside the mask may help combat respiratory diseases such as COVID-19. […]
The hormone acts as a barrier against SARS-CoV-2, blocking the expression of genes that encode proteins in cells serving as viral entry points, according to a study by researchers at the University of São Paulo. Melatonin synthesized in the lungs acts as a barrier against the virus, preventing expression of […]
In an effort to expedite care for coronavirus disease 2019 (COVID-19) patients upon hospital admission, a team at The Feinstein Institutes for Medical Research has developed a machine learning (ML) artificial intelligence (AI) powered clinical predictive tool that can accurately assess patients for the risk of respiratory failure within 48 hours. […]
An unusual experiment to prevent nursing home staff members and residents from infection with the coronavirus has succeeded, the drug maker Eli Lilly announced on January 21, 2021. A drug containing monoclonal antibodies — laboratory-grown virus-fighters — prevented symptomatic infections in residents who were exposed to the virus, even the […]
Apnimed, a clinical-stage pharmaceutical company focused on developing oral medicines to treat Obstructive Sleep Apnea (OSA) and related disorders, today announced that the first patient has been dosed in a Phase 2 clinical trial evaluating AD109 as a treatment for mild to moderate OSA. If successful, AD109 could offer an […]
